TDP-43 Proteinopathies in ALS-Dementia

ALS 痴呆中的 TDP-43 蛋白病

基本信息

批准号：
8534672
负责人：
VIRGINIA M LEE
金额：
$ 109.35万
依托单位：
UNIVERSITY OF PENNSYLVANIA
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
起止时间：
2010-09-30 至 2015-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8534672
关键词：
Address Advocacy Affect Algorithms Alzheimer&apos s Disease Amyloid Amyotrophic Lateral Sclerosis Animal Model Authorship Autopsy Award Basic Science Behavioral Biochemistry Biological Biological Markers Biological Models Biometry Biostatistics Core Blood Brain C-terminal Cell Culture Techniques Cell Nucleus Cells Cessation of life Cleaved cell Clinic Clinical Clinical Management Clinical Research Clinical Sciences Cognition Cognitive Collaborations Communities Consent Consult Consultations Cytoplasm DNA Data Data Analyses Databases Dementia Development Diagnosis Diagnostic Diagnostic tests Disease Ensure Environment Etiology Exhibits Extramural Activities Faculty Family Feasibility Studies Fostering Frontotemporal Lobar Degenerations Functional disorder Funding Mechanisms Future Gene Mutation Generations Genetic Goals Grant Health Health system Hospitals Human Impaired cognition In Vitro Interdisciplinary Study International Intervention Joints Laboratories Language Language Disorders Lead Linguistics Link Magnetic Resonance Imaging Manuscripts Measures Mediating Medicine Metabolism Methodology Modeling Modification Molecular Molecular Biology Motor Motor Neuron Disease Mutation N-terminal Nature Nerve Degeneration Neuroanatomy Neurodegenerative Disorders Neuronal Dysfunction Neurons Neuropsychology Neurosciences Nuclear Nuclear Export Nuclear Localization Signal Paper Pathogenesis Pathology Patients Peer Review Pennsylvania Phenotype Phosphorylation Site Physicians Plasma Policies Process Program Research Project Grants Property Proteins Publications Publishing RNA Splicing Reagent Recording of previous events Recruitment Activity Research Research Design Research Personnel Research Project Grants Resources Risk Factors Role Sampling Science Scientist Sensory Services Signal Transduction Site Solid Source Spinal Cord Staging Structure Syndrome System TNFRSF5 gene Techniques Testing Therapeutic Agents Time Tissue Sample Tissues Transgenic Mice Translating Ubiquitin United States National Institutes of Health Universities Variant Work antibody-dependent cell cytotoxicity base brain tissue career clinical phenotype data management data sharing design disease-causing mutation disorder risk dissemination research experience frontal lobe functional loss genetic variant human subject improved in vitro Model in vivo in vivo Model insight interest kindred meetings member motor deficit motor disorder motor impairment mouse model multidisciplinary mutant neuropathology novel novel therapeutics patient oriented patient oriented research programs protein TDP-43 ranpirnase relating to nervous system relational database repository research study skills theories trafficking transgene expression translational study

项目摘要

Ubiquitin positive inclusions are found in amyotrophic lateral sclerosis (ALS), a prototypic motor neuron disease and frontotemporal lobar degeneration (FTLD), the second most common dementia after Alzheimer's disease in patients <65. Recently, investigators at the University of Pennsylvania (PENN) identified TDP-43 as the disease protein ubiquitinated in both disorders. Since motor neuron disease and dementia are found in ALS and FTLD, and since the same disease protein accumulates in both disease entities, this suggests that ALS and FTLD represent the same clinicopathological spectrum of a neurodegenerative syndrome. Thus, the major goals of this Program Project Grant (PPG) is to develop a vigorous research program focused on elucidating the etiology and pathogenesis of TDP-43 proteinopathies in ALS without or with cognitive impairment or dementia (designated as ALS, ALS-Cog and ALS-FTLD, respectively) and compare them to FTLD with and without ALS. The investigators of this new PPG are a close-knit and highly integrated multidisciplinary group of PENN physicians and basic scientists who have formed a productive collaborative alliance and established a very comprehensive clinical and basic science research program at PENN to study ALS, ALS-Cog and ALS-FTLD in patients, in human postmortem tissues and in model systems. These investigators propose a set of bold objectives for ALS and FTLD research that will be implemented through 4 Cores and 3 Projects. Specifically, they will: 1) recruit ALS, ALS-Cog and ALS-FTLD patients; 2) develop new algorithms to characterize the cognitive impairments and dementia in ALS patients; 3) test the hypothesis that there is a tight link between language and motor systems in the representation of action verbs; 4) further characterize the spectrum of TDP-43 neuropathologies in ALS, ALS-Cog and ALS-FTLD brains and compare them with FTLD with and without ALS; 5) identify hyperphosphorylated residues and N-terminal cleavage sites that generate C-terminal fragments in pathological TDP-43 and determine their significance in mechanisms of TDP-43 proteinopathies; 6) establish cell culture and transgenic mouse models of TDP-43; 7) use these models to elucidate the pathogenic mechanisms of neurodegeneration in TDP-43; 8) determine if genetic variants in TDP-43 found in patients with ALS, ALS-Cog and ALS-FTLD are disease risk factors or pathogenic disease causing mutations; These and other studies will lead to improved understanding of the cognitive impairments and dementia in ALS as well as provide insights on the diagnosis and treatment of these disorders.

泛素阳性包涵体存在于肌萎缩侧索硬化症 (ALS)（一种典型的运动神经元疾病）和额颞叶变性 (FTLD) 中，后者是 65 岁以下患者中仅次于阿尔茨海默病的第二常见痴呆症。最近，宾夕法尼亚大学 (PENN) 的研究人员确定 TDP-43 是两种疾病中泛素化的疾病蛋白。由于运动神经元疾病和痴呆在 ALS 和 FTLD 中发现，并且由于相同的疾病蛋白在两种疾病实体中积累，这表明 ALS 和 FTLD 代表神经退行性综合征的相同临床病理学谱。因此，该计划项目拨款 (PPG) 的主要目标是制定一项强有力的研究计划，重点是阐明 ALS 中 TDP-43 蛋白病的病因和发病机制，其中 ALS 不伴有或伴有认知障碍或痴呆（称为 ALS、ALS-Cog 和 ALS）。 ALS-FTLD，分别）并将它们与有和没有 ALS 的 FTLD 进行比较。这个新的 PPG 的研究人员是一个由 PENN 医生和基础科学家组成的紧密且高度整合的多学科小组，他们形成了富有成效的合作联盟，并在 PENN 建立了非常全面的临床和基础科学研究项目，以研究 ALS、ALS-Cog 和患者、人类死后组织和模型系统中的 ALS-FTLD。这些研究人员为 ALS 和 FTLD 研究提出了一系列大胆的目标，这些目标将通过 4 个核心和 3 个项目来实施。具体来说，他们将： 1）招募 ALS、ALS-Cog 和 ALS-FTLD 患者； 2）开发新的算法来表征ALS患者的认知障碍和痴呆症； 3）检验以下假设：在动作动词的表示中，语言和运动系统之间存在紧密联系； 4) 进一步表征 ALS、ALS-Cog 和 ALS-FTLD 大脑中 TDP-43 神经病理学的谱，并将它们与有和没有 ALS 的 FTLD 进行比较； 5) 鉴定在病理性TDP-43中产生C端片段的过度磷酸化残基和N端切割位点，并确定它们在TDP-43蛋白病机制中的重要性； 6)建立TDP-43的细胞培养和转基因小鼠模型； 7）利用这些模型阐明TDP-43神经变性的致病机制； 8) 确定 ALS、ALS-Cog 和 ALS-FTLD 患者中发现的 TDP-43 基因变异是否是疾病危险因素或致病突变；这些研究和其他研究将提高对 ALS 认知障碍和痴呆症的了解，并为这些疾病的诊断和治疗提供见解。